Alkem Laboratories is currently trading at Rs. 2714.00, up by 64.90 points or 2.45% from its previous closing of Rs. 2649.10 on the BSE.
The scrip opened at Rs. 2650.00 and has touched a high and low of Rs. 2722.40 and Rs. 2650.00 respectively. So far 4645 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 3150.00 on 27-Jan-2021 and a 52 week low of Rs. 2223.55 on 27-May-2020.
Last one week high and low of the scrip stood at Rs. 2722.40 and Rs. 2544.25 respectively. The current market cap of the company is Rs. 32308.85 crore.
The promoters holding in the company stood at 62.43%, while Institutions and Non-Institutions held 17.04% and 20.53% respectively.
Alkem Laboratories has agreed in principle to subscribe to a partnership interest in ABCD Technologies LLP (to be renamed as IndoHealth services LLP). The Target entity is a recently incorporated limited liability partnership (LLP) and has not commenced any business activities.
Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.Karnataka Bank has operationalized its wholly owned non-financial subsidiary 'KBL Services'. The KBL Services is having its Registered & Head Office at Bengaluru. This subsidiary of the Bank is established as conceptualized under the transformation journey 'KBL - VIKAAS' in achieving Bank's strategic objectives in the long run.
Karnataka Bank operates as a private sector bank. Its products and services include current account, demand, time, cumulative, cash certificates, insurance linked savings bank deposits, resident foreign currency accounts and senior citizens deposit schemes.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1817.60 |
Dr. Reddys Lab | 1351.25 |
Cipla | 1475.90 |
Lupin | 2168.30 |
Zydus Lifesciences | 964.40 |
View more.. |